
Mikie Sherrill Periodic Transaction Report
Filed May 15, 2024 · House Clerk · 1 transaction
U.S. Representative · D · NJ-11 · All trades by Mikie Sherrill
On May 15, 2024, Rep. Mikie Sherrill (D-NJ-11) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated May 14, 2024.
The filing covers 1 ticker, including $UBS.
Reported amount ranges sum to $50K–$100K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 1 day.
1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20025087
Sample · the intelligence layer
Mikie Sherrill · Sold $UBS · May 14 · $50K–$100K
Coldpine’s read
The one-day disclosure lag is notably fast, meaning the market may not have absorbed this filing when it appeared. This partial sale of UBS shares, held jointly, falls within a mid-range $50,001–$100,000 disclosed bracket. No other members traded UBS in the same direction within 30 days, so this stands as an isolated sale rather than cluster activity.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Mikie Sherrill
Get an email the moment Mikie Sherrill files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| May 14, 2024 | UBSUBSUBS Group AG Registered Ordinary Shares (UBS) [ST] | UBS Group AG Registered Ordinary Shares (UBS) [ST] | sell | Joint | $50K–$100K | 1d |
Other recent filings by Mikie Sherrill
- PTR filed Mar 10, 20251 trade · UBS
- PTR filed May 13, 20241 trade · UBS
- PTR filed Mar 3, 20231 trade · UBS
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →